Kimaritec PTY LTD

Kimaritec is developing new therapies for cancer, by manipulating the body’s protein recycling pathway to drive protein degradation of critical oncoproteins. Cancer remains a disease with high unmet medical need, with many patients succumbing to tumours which become unresponsive to current therapy. Clinicians and patients are looking for new approaches to eradicate or slow progression of cancer. Kimaritec is taking a novel approach to selectively degrade proteins important for cancer growth and metastasis. It is hoped that by harnessing this novel the protein degradation pathway, Kimaritec will develop new anti-cancer therapies.